Neurological outcome of a patient with Gaucher disease type III treated by enzymatic replacement therapy

J Inherit Metab Dis. 1998 Feb;21(1):74-6. doi: 10.1023/a:1005319632539.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Child, Preschool
  • Follow-Up Studies
  • Gaucher Disease / drug therapy*
  • Gaucher Disease / enzymology
  • Gaucher Disease / physiopathology
  • Glucosylceramidase / therapeutic use*
  • Humans
  • Male
  • Neurologic Examination
  • Treatment Outcome

Substances

  • alglucerase
  • Glucosylceramidase